(Q58236138)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613746%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613746%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613746%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

W M Wong

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613746%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P C Wu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613746%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M F Yuen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613746%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C C Cheng

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613746%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

W W Yew

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613746%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P C Wong

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613746%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C M Tam

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613746%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C C Leung

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613746%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613746%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613746%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613746%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613746%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

201-206

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613746%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of tuberculosis in the United States, 1985 through 1992.

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310129

7 January 2021

Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 month

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310129

7 January 2021

Rifampicin hepatitis. A clinical and histological study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310129

7 January 2021

Toxic hepatitis with isoniazid and rifampin. A meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310129

7 January 2021

A prospective clinical study of isoniazid-rifampicin-pyrazinamide-induced liver injury in an area endemic for hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310129

7 January 2021

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310129

7 January 2021

Anti-tuberculosis medication and the liver: dangers and recommendations in management

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310129

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310129

7 January 2021

Natural history of chronic hepatitis B virus infection: new light on an old story.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310129

7 January 2021

Re-evaluation of α-interferon treatment of chronic hepatitis B using polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310129

7 January 2021

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310129

7 January 2021

Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310129

7 January 2021

Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310129

7 January 2021

Identifiers

DOI

10.1002/HEP.510310129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613746%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference